These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23836286)

  • 1. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
    Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
    Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class I recognition by monocyte-/macrophage-specific receptors.
    Yoshida R
    Adv Immunol; 2014; 124():207-47. PubMed ID: 25175777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
    Tashiro-Yamaji J; Kubota T; Yoshida R
    Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgene number-dependent, gene expression rate-independent rejection of Dd -, Kd-, or Dd Kd -transgened mouse skin or tumor cells from C57BL/6 Db Kb mice.
    Inoue Y; Tashiro-Yamaji J; Hayashi M; Kiyonari H; Shimizu T; Ibata M; Yamana H; Kubota T; Tanigawa N; Yoshida R
    Microbiol Immunol; 2011 Jun; 55(6):446-53. PubMed ID: 21434990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulated expression of monocyte/macrophage major histocompatibility complex receptors in human and mouse monocytes by expression of their ligands.
    Yamana H; Tashiro-Yamaji J; Hayashi M; Maeda S; Shimizu T; Tanigawa N; Uchiyama K; Kubota T; Yoshida R
    Clin Exp Immunol; 2014 Oct; 178(1):118-28. PubMed ID: 24842626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B62 as a possible ligand for the human homologue of mouse macrophage MHC receptor 2 (MMR2) on monocytes.
    Shimizu T; Tashiro-Yamaji J; Hayashi M; Inoue Y; Ibata M; Kubota T; Tanigawa N; Yoshida R
    Gene; 2010 Apr; 454(1-2):31-8. PubMed ID: 20123006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding of HLA-B44 to human macrophage MHC receptor 1 on monocytes.
    Tashiro-Yamaji J; Shimizu T; Hayashi M; Yamana H; Tanigawa N; Uchiyama K; Kubota T; Yoshida R
    Gene; 2012 Jun; 501(2):127-34. PubMed ID: 22525042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allograft rejection by T cell receptor transgenic mice.
    Bassiri H; Markmann JF; Desai NM; Kim JI; Teh HS; Barker CF
    J Surg Res; 1993 May; 54(5):437-44. PubMed ID: 8361170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel receptor on allograft (H-2d)-induced macrophage (H-2b) toward an allogeneic major histocompatibility complex class I molecule, H-2Dd, in mice.
    Tashiro-Yamaji J; Einaga-Naito K; Kubota T; Yoshida R
    Microbiol Immunol; 2006; 50(2):105-16. PubMed ID: 16490928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.
    Lee MK; Huang X; Jarrett BP; Moore DJ; Desai NM; Moh Lian M; Markmann JW; Deng S; Frank A; Singer A; Velidedeoglu E; Caton AJ; Markmann AJ
    Transplantation; 2003 Apr; 75(8):1415-22. PubMed ID: 12717241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
    Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
    Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
    Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
    J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
    Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection.
    Brennan TV; Hoang V; Garrod KR; Liu FC; Hayden T; Kim J; Kang SM
    Transplantation; 2008 Jan; 85(2):247-55. PubMed ID: 18212630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.